Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Description: Topical gel for erectile dysfunction
Status: EU regulatory approval granted. Supplementary study required for US. Specialist corporate advisers appointed
Description: Topical diclofenac pain relief gel
Status: Phase 3 study required.
Description: Topical cannabidiol formulation
Status: Joint venture colaboration. Early development stage to explore a number of disease states including pain relief.